New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?

There is tremendous market and media frenzy around new Alzheimer’s disease drugs, but their efficacy is contested while the potential of prevention is untapped and underreported, Drs. Lee Hood and Nathan Price wrote in an opinion piece published by the Los Angeles Times.

New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?
New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?

“Armchair Expert with Dax Shepard” podcast welcomes Lee Hood and Nathan Price

Drs. Lee Hood and Nathan Price, authors of “The Age of Scientific Wellness,” were interviewed by actor and podcaster Dax Sheperd about their new book, and they discussed how AI is changing the medical industry, how infectious disease has impacted our world, the effectiveness of prescriptions, and much more.

“Armchair Expert with Dax Shepard” podcast welcomes Lee Hood and Nathan Price
“Armchair Expert with Dax Shepard” podcast welcomes Lee Hood and Nathan Price
screenshot for video on Beyond the Scale: How Multiomics and Biological BMI Can Help Achieve Optimal Health

Beyond the Scale: How Multiomics and Biological BMI Can Help Achieve Optimal Health

ISB researchers have constructed a biological BMI that provides a more accurate representation of metabolic health and is more varied, informative and actionable than the long-used classical BMI. ISB Senior Research Scientist Dr. Noa Rappaport discussed biological BMI in a Research Roundtable presentation. 

Beyond the Scale: How Multiomics and Biological BMI Can Help Achieve Optimal Health
Beyond the Scale: How Multiomics and Biological BMI Can Help Achieve Optimal Health
screenshot of video for COCOA Trial Results Show Diet, Exercise Help Some with Dementia

COCOA Trial Results Show Diet, Exercise Help Some with Dementia

The recently completed, ISB-led Coaching for Cognition in Alzheimer’s (COCOA) trial shows that diet and exercise can help people suffering from dementia. Senior Research Scientist Dr. Jared Roach discussed the findings in a Research Roundtable presentation.

COCOA Trial Results Show Diet, Exercise Help Some with Dementia
COCOA Trial Results Show Diet, Exercise Help Some with Dementia
Wilmanski-Gibbons

Gut Microbiome Composition Predictive of Patient Response to Statins

New ISB research shows that different patient responses to statins can be explained by the variation in the human microbiome. The findings were published in the journal Med, and suggest that microbiome monitoring could be used to help optimize personalized statin treatments.

Gut Microbiome Composition Predictive of Patient Response to Statins
Gut Microbiome Composition Predictive of Patient Response to Statins
1 2 3 4 6